F-18 T808Alternative Names: [F-18]T808; Fluorine-18 T808; Tau [F-18]T808
Latest Information Update: 16 Jul 2016
At a glance
- Originator Siemens Medical Solutions
- Class Radiopharmaceutical diagnostics
- Mechanism of Action Positron-emission tomography enhancers
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Alzheimer's disease
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-0 development in Alzheimer's-disease in USA (IV, Injection)
- 31 Jul 2012 Phase-0 for Alzheimer's disease in USA (IV)